Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12205071rdf:typepubmed:Citationlld:pubmed
pubmed-article:12205071lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C0007546lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C0162367lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C1996904lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C0439810lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C0678587lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C1880497lld:lifeskim
pubmed-article:12205071lifeskim:mentionsumls-concept:C0444889lld:lifeskim
pubmed-article:12205071pubmed:issue3lld:pubmed
pubmed-article:12205071pubmed:dateCreated2002-9-2lld:pubmed
pubmed-article:12205071pubmed:abstractTextFree and total concentrations of cefazolin were compared in plasma and interstitial fluid during continuous intravenous infusion therapy. Seven patients, median age 53 (25-74) years, were administered a constant infusion of cefazolin at a mean (+/-S.D.) dose of 3.5 g (+/-1.1) per 24 h for > or = 5 days. Four blisters were induced on the forearm of each patient for sampling of interstitial fluid. Free concentrations in plasma and interstitial fluid were similar, and correlated better than total concentrations (r(2) = 0.82, P = 0.005 versus r(2) = 0.54, P = 0.056). In all patients, the free concentrations in the interstitial fluid were at least two-fold the MIC(90) for Staphylococcus aureus.lld:pubmed
pubmed-article:12205071pubmed:languageenglld:pubmed
pubmed-article:12205071pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12205071pubmed:citationSubsetIMlld:pubmed
pubmed-article:12205071pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12205071pubmed:statusMEDLINElld:pubmed
pubmed-article:12205071pubmed:monthSeplld:pubmed
pubmed-article:12205071pubmed:issn0305-7453lld:pubmed
pubmed-article:12205071pubmed:authorpubmed-author:ZhangMeiMlld:pubmed
pubmed-article:12205071pubmed:authorpubmed-author:KirkpatrickCa...lld:pubmed
pubmed-article:12205071pubmed:authorpubmed-author:BeggEvan JEJlld:pubmed
pubmed-article:12205071pubmed:authorpubmed-author:ChambersSteph...lld:pubmed
pubmed-article:12205071pubmed:authorpubmed-author:HowardGrant...lld:pubmed
pubmed-article:12205071pubmed:authorpubmed-author:Vella...lld:pubmed
pubmed-article:12205071pubmed:issnTypePrintlld:pubmed
pubmed-article:12205071pubmed:volume50lld:pubmed
pubmed-article:12205071pubmed:ownerNLMlld:pubmed
pubmed-article:12205071pubmed:authorsCompleteYlld:pubmed
pubmed-article:12205071pubmed:pagination429-32lld:pubmed
pubmed-article:12205071pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:meshHeadingpubmed-meshheading:12205071...lld:pubmed
pubmed-article:12205071pubmed:year2002lld:pubmed
pubmed-article:12205071pubmed:articleTitleFree and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion.lld:pubmed
pubmed-article:12205071pubmed:affiliationDepartment of Clinical Pharmacology, Christchurch Hospital, PO Box 4710, Christchurch, New Zealand.lld:pubmed
pubmed-article:12205071pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12205071lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12205071lld:pubmed